Select an emerging issue that will pose new ethical dilemmas for healthcare. For example, technology integration, innovation testing, genetic mapping, stem cell research, etc.
1. Using APA format, analyze whether global competition affects U.S. healthcare policy?
2. For example, stem cell research in Europe but not here, how will that affect our economy and our health care options?
3. Also indicate, how the U.S. should handle licensing and liability issues for clinicians practicing telemedicine across state or national borders.
I need help with these questions for ideas and insights? Thank you.
A tentative outline might look something to the effect:
II. Ethics and Policies on Genetic Mapping
A. US Policies (e.g., genetic mapping, transplants- fetus, embyoinic stem cell, brain cells; research, etc.)
B. Economic and health choices Implications
C. Practice of Telemedicine across state of national borders (e.g. license and liability, etc.)
III. Conclusions (e.g. sum up main points)
Now let’s look at some information for each section for you to consider.
Genetic mapping has a fairly short history. In 1990, the Human Genome Project (HGP) was initiated ito support and coordinate efforts of the National Institutes of Health (NIH) and the Department of Energy (DOE) to produce a complete genetic map of all human genes. The Ethical, Legal, and Social Implications (ELSI) Program of the HGP was charged with anticipating the social consequences of the acquisition of this knowledge and developing policies to guide its use. With 5% of the genome budget supporting ELSI activities, the ELSI Program is both the first federally supported extramural research initiative in ethical issues and the largest source of public funds for bioethics (http://www.acnp.org/G4/GN401000180/CH176.html).
There is a rising demand for genetic information. In the United States, for example, demand has led to the growth of private genetics services that are marketed directly to the public. On the other hand, in the United Kingdom, specialist genetic services have increased workloads and recognized the need for some genetics services will have to be incorporated into mainstream clinical medicine, particularly at primary care level. Genetic mapping of diseases, such as Parkinson’s disease has also resulted in ethical issues related to transplants using fetal and embryonic stem cells (Kinmonth, Reinhard, Bobrow & Pauker, 1995, as cited in http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1112731)…………PLACE ORDER FOR A COMPLETE AND CUSTOMIZED ANSWER……….